Hypoxia inducible factor 1α: A critical factor for the immune response to pathogens and Leishmania

Cellular Immunology

Volumn 309, Issue , 2016, Pages 42-49

  Charpentier, Tania ^a,b   Hammami, Akil ^a,b   Stäger, Simona ^a,b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b Department of Microbiology and Immunology   (Canada)

Author keywords

HIF 1 ; Immunoregulation; Immunosuppression; Inflammation; Leishmania; Pathogens

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN;

ARTICLE; BACTERIAL INFECTION; DENDRITIC CELL; HUMAN; HYPOXIA; IMMUNE SYSTEM; INFLAMMATION; LEISHMANIA; MACROPHAGE; MICROBIAL IMMUNITY; MICROENVIRONMENT; NEUTROPHIL; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; T LYMPHOCYTE; VIRUS INFECTION; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNITY; IMMUNOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNE EVASION; IMMUNITY; INFLAMMATION; LEISHMANIA; SIGNAL TRANSDUCTION;

EID: 84977647129     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2016.06.002     Document Type: Article

References (134)

1. [1] Nizet, V., Johnson, R.S., Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9 (2009), 609–617.
2. [2] Schor, H., Vaday, G.G., Lider, O., Modulation of leukocyte behavior by an inflamed extracellular matrix. Dev. Immunol. 7 (2000), 227–238.
3. [3] Saadi, S., Wrenshall, L.E., Platt, J.L., Regional manifestations and control of the immune system. FASEB J. 16 (2002), 849–856.
4. [4] Semenza, G.L., Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7 (2001), 345–350.
5. [5] Semenza, G.L., Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr. Opin. Genet. Dev. 8 (1998), 588–594.
6. [6] Semenza, G.L., Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15 (1999), 551–578.
7. [7] Semenza, G.L., Wang, G.L., A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12 (1992), 5447–5454.
8. [8] Wang, G.L., Semenza, G.L., Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270 (1995), 1230–1237.
9. [9] Tian, H., McKnight, S.L., Russell, D.W., Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11 (1997), 72–82.
10. [10] Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414 (2001), 550–554.
11. [11] Walmsley, S.R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R.S., et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J. Exp. Med. 201 (2005), 105–115.
12. [12] Cramer, T., Yamanishi, Y., Clausen, B.E., Forster, I., Pawlinski, R., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112 (2003), 645–657.
13. [13] Jantsch, J., Chakravortty, D., Turza, N., Prechtel, A.T., Buchholz, B., et al. Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J. Immunol. 180 (2008), 4697–4705.
14. [14] McNamee, E.N., Korns Johnson, D., Homann, D., Clambey, E.T., Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function. Immunol. Res. 55 (2013), 58–70.
15. [15] Palazon, A., Goldrath, A.W., Nizet, V., Johnson, R.S., HIF transcription factors, inflammation, and immunity. Immunity 41 (2014), 518–528.
16. [16] Talks, K.L., Turley, H., Gatter, K.C., Maxwell, P.H., Pugh, C.W., et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157 (2000), 411–421.
17. [17] Imtiyaz, H.Z., Williams, E.P., Hickey, M.M., Patel, S.A., Durham, A.C., et al. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J. Clin. Invest. 120 (2010), 2699–2714.
18. [18] Doedens, A.L., Phan, A.T., Stradner, M.H., Fujimoto, J.K., Nguyen, J.V., et al. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat. Immunol. 14 (2013), 1173–1182.
19. [19] Prabhakar, N.R., Semenza, G.L., Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol. Rev. 92 (2012), 967–1003.
20. [20] Hubbi, M.E., Gilkes, D.M., Hu, H., Kshitiz, Ahmed.I., et al. Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1alpha to promote cell-cycle progression. Proc. Natl. Acad. Sci. U S A 111 (2014), E3325–E3334.
21. [21] Wenger, R.H., Stiehl, D.P., Camenisch, G., Integration of oxygen signaling at the consensus HRE. Sci. STKE, 2005, 2005, re12.
22. [22] Semenza, G.L., Jiang, B.H., Leung, S.W., Passantino, R., Concordet, J.P., et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271 (1996), 32529–32537.
23. [23] Semenza, G.L., Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu. Rev. Pathol. 9 (2014), 47–71.
24. [24] Jaakkola, P., Mole, D.R., Tian, Y.M., Wilson, M.I., Gielbert, J., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001), 468–472.
25. [25] Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292 (2001), 464–468.
26. [26] Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O'Rourke, J., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001), 43–54.
27. [27] Yu, F., White, S.B., Zhao, Q., Lee, F.S., HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. U S A 98 (2001), 9630–9635.
28. [28] Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999), 271–275.
29. [29] Ohh, M., Park, C.W., Ivan, M., Hoffman, M.A., Kim, T.Y., et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2 (2000), 423–427.
30. [30] Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J., Whitelaw, M.L., Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295 (2002), 858–861.
31. [31] Mahon, P.C., Hirota, K., Semenza, G.L., FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15 (2001), 2675–2686.
32. [32] Lando, D., Peet, D.J., Gorman, J.J., Whelan, D.A., Whitelaw, M.L., et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16 (2002), 1466–1471.
33. [33] Lim, J.H., Lee, Y.M., Chun, Y.S., Chen, J., Kim, J.E., et al. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell 38 (2010), 864–878.
34. [34] Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 131 (2007), 309–323.
35. [35] Hubbi, M.E., Semenza, G.L., Regulation of cell proliferation by hypoxia-inducible factors. Am. J. Physiol. Cell Physiol., 2015 ajpcell 00279 02015.
36. [36] Kaelin, W.G. Jr., Ratcliffe, P.J., Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30 (2008), 393–402.
37. [37] Brunelle, J.K., Bell, E.L., Quesada, N.M., Vercauteren, K., Tiranti, V., et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1 (2005), 409–414.
38. [38] Pan, Y., Mansfield, K.D., Bertozzi, C.C., Rudenko, V., Chan, D.A., et al. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol. Cell. Biol. 27 (2007), 912–925.
39. [39] Mansfield, K.D., Guzy, R.D., Pan, Y., Young, R.M., Cash, T.P., et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab. 1 (2005), 393–399.
40. [40] Masson, N., Singleton, R.S., Sekirnik, R., Trudgian, D.C., Ambrose, L.J., et al. The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity. EMBO Rep. 13 (2012), 251–257.
41. [41] Huang, C., Han, Y., Wang, Y., Sun, X., Yan, S., et al. SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J. 28 (2009), 2748–2762.
42. [42] Lombard, D.B., Alt, F.W., Cheng, H.L., Bunkenborg, J., Streeper, R.S., et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 27 (2007), 8807–8814.
43. [43] Greer, S.N., Metcalf, J.L., Wang, Y., Ohh, M., The updated biology of hypoxia-inducible factor. EMBO J. 31 (2012), 2448–2460.
44. [44] Bell, E.L., Emerling, B.M., Ricoult, S.J., Guarente, L., SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production. Oncogene 30 (2011), 2986–2996.
45. [45] Finley, L.W., Carracedo, A., Lee, J., Souza, A., Egia, A., et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 19 (2011), 416–428.
46. [46] Liu, Y.V., Baek, J.H., Zhang, H., Diez, R., Cole, R.N., et al. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol. Cell 25 (2007), 207–217.
47. [47] Baek, J.H., Liu, Y.V., McDonald, K.R., Wesley, J.B., Hubbi, M.E., et al. Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1alpha. J. Biol. Chem. 282 (2007), 23572–23580.
48. [48] Hubbi, M.E., Hu, H., Kshitiz, Ahmed.I., Levchenko, A., et al. Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation. J. Biol. Chem. 288 (2013), 10703–10714.
49. [49] Ferreira, J.V., Fofo, H., Bejarano, E., Bento, C.F., Ramalho, J.S., et al. STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy. Autophagy 9 (2013), 1349–1366.
50. [50] Haddad, J.J., Recombinant human interleukin (IL)-1 beta-mediated regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) stabilization, nuclear translocation and activation requires an antioxidant/reactive oxygen species (ROS)-sensitive mechanism. Eur. Cytokine Netw. 13 (2002), 250–260.
51. [51] Jung, Y., Isaacs, J.S., Lee, S., Trepel, J., Liu, Z.G., et al. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem. J. 370 (2003), 1011–1017.
52. [52] Albina, J.E., Mastrofrancesco, B., Vessella, J.A., Louis, C.A., Henry, W.L. Jr, et al. HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am. J. Physiol. Cell Physiol. 281 (2001), C1971–C1977.
53. [53] Frede, S., Stockmann, C., Freitag, P., Fandrey, J., Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem J 396 (2006), 517–527.
54. [54] Blouin, C.C., Page, E.L., Soucy, G.M., Richard, D.E., Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 103 (2004), 1124–1130.
55. [55] Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A.S., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453 (2008), 807–811.
56. [56] Schofield, C.J., Ratcliffe, P.J., Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5 (2004), 343–354.
57. [57] Arany, Z., Huang, L.E., Eckner, R., Bhattacharya, S., Jiang, C., et al. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. U S A 93 (1996), 12969–12973.
58. [58] Yuan, G., Nanduri, J., Khan, S., Semenza, G.L., Prabhakar, N.R., Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR. J. Cell. Physiol. 217 (2008), 674–685.
59. [59] Manalo, D.J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B.D., et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105 (2005), 659–669.
60. [60] Xia, X., Lemieux, M.E., Li, W., Carroll, J.S., Brown, M., et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc. Natl. Acad. Sci. U S A 106 (2009), 4260–4265.
61. [61] Schodel, J., Oikonomopoulos, S., Ragoussis, J., Pugh, C.W., Ratcliffe, P.J., et al. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117 (2011), e207–e217.
62. [62] Semenza, G.L., Hypoxia-inducible factor 1 and cardiovascular disease. Annu. Rev. Physiol. 76 (2014), 39–56.
63. [63] Seagroves, T.N., Ryan, H.E., Lu, H., Wouters, B.G., Knapp, M., et al. Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol. Cell. Biol. 21 (2001), 3436–3444.
64. [64] Kim, J.W., Tchernyshyov, I., Semenza, G.L., Dang, C.V., HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3 (2006), 177–185.
65. [65] Papandreou, I., Cairns, R.A., Fontana, L., Lim, A.L., Denko, N.C., HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3 (2006), 187–197.
66. [66] Lu, C.W., Lin, S.C., Chen, K.F., Lai, Y.Y., Tsai, S.J., Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J. Biol. Chem. 283 (2008), 28106–28114.
67. [67] Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 29 (2009), 2570–2581.
68. [68] Zhang, H., Bosch-Marce, M., Shimoda, L.A., Tan, Y.S., Baek, J.H., et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 283 (2008), 10892–10903.
69. [69] Du, R., Lu, K.V., Petritsch, C., Liu, P., Ganss, R., et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13 (2008), 206–220.
70. [70] Lee, K., Qian, D.Z., Rey, S., Wei, H., Liu, J.O., et al. Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. Proc. Natl. Acad. Sci. U S A 106 (2009), 2353–2358.
71. [71] Shortman, K., Naik, S.H., Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7 (2007), 19–30.
72. [72] Steinman, R.M., Dendritic cells: understanding immunogenicity. Eur. J. Immunol. 37:Suppl 1 (2007), S53–S60.
73. [73] Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000), 767–811.
74. [74] Lanzavecchia, A., Sallusto, F., Regulation of T cell immunity by dendritic cells. Cell 106 (2001), 263–266.
75. [75] Banchereau, J., Steinman, R.M., Dendritic cells and the control of immunity. Nature 392 (1998), 245–252.
76. [76] Elia, A.R., Cappello, P., Puppo, M., Fraone, T., Vanni, C., et al. Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile. J. Leukoc. Biol. 84 (2008), 1472–1482.
77. [77] Mancino, A., Schioppa, T., Larghi, P., Pasqualini, F., Nebuloni, M., et al. Divergent effects of hypoxia on dendritic cell functions. Blood 112 (2008), 3723–3734.
78. [78] Jantsch, J., Wiese, M., Schodel, J., Castiglione, K., Glasner, J., et al. Toll-like receptor activation and hypoxia use distinct signaling pathways to stabilize hypoxia-inducible factor 1alpha (HIF1A) and result in differential HIF1A-dependent gene expression. J. Leukoc. Biol. 90 (2011), 551–562.
79. [79] Krawczyk, C.M., Holowka, T., Sun, J., Blagih, J., Amiel, E., et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115 (2010), 4742–4749.
80. [80] Bhandari, T., Olson, J., Johnson, R.S., Nizet, V., HIF-1alpha influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination. J Mol Med (Berl) 91 (2013), 1199–1205.
81. [81] Peyssonnaux, C., Datta, V., Cramer, T., Doedens, A., Theodorakis, E.A., et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115 (2005), 1806–1815.
82. [82] Anand, R.J., Gribar, S.C., Li, J., Kohler, J.W., Branca, M.F., et al. Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1alpha-dependent manner. J. Leukoc. Biol. 82 (2007), 1257–1265.
83. [83] Zhou, J., Dehne, N., Brune, B., Nitric oxide causes macrophage migration via the HIF-1-stimulated small GTPases Cdc42 and Rac1. Free Radic. Biol. Med. 47 (2009), 741–749.
84. [84] Kong, T., Eltzschig, H.K., Karhausen, J., Colgan, S.P., Shelley, C.S., Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proc. Natl. Acad. Sci. U S A 101 (2004), 10440–10445.
85. [85] Colegio, O.R., Chu, N.Q., Szabo, A.L., Chu, T., Rhebergen, A.M., et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513 (2014), 559–563.
86. [86] Roiniotis, J., Dinh, H., Masendycz, P., Turner, A., Elsegood, C.L., et al. Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J. Immunol. 182 (2009), 7974–7981.
87. [87] Caldwell, C.C., Kojima, H., Lukashev, D., Armstrong, J., Farber, M., et al. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 167 (2001), 6140–6149.
88. [88] Lukashev, D., Klebanov, B., Kojima, H., Grinberg, A., Ohta, A., et al. Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J. Immunol. 177 (2006), 4962–4965.
89. [89] Brenner, S., Prosch, S., Schenke-Layland, K., Riese, U., Gausmann, U., et al. CAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J. Biol. Chem. 278 (2003), 5597–5604.
90. [90] Panther, E., Corinti, S., Idzko, M., Herouy, Y., Napp, M., et al. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 101 (2003), 3985–3990.
91. [91] Ben-Shoshan, J., Maysel-Auslender, S., Mor, A., Keren, G., George, J., Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur. J. Immunol. 38 (2008), 2412–2418.
92. [92] Lukashev, D., Caldwell, C., Ohta, A., Chen, P., Sitkovsky, M., Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes. J. Biol. Chem. 276 (2001), 48754–48763.
93. [93] Nakamura, H., Makino, Y., Okamoto, K., Poellinger, L., Ohnuma, K., et al. TCR engagement increases hypoxia-inducible factor-1 alpha protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J. Immunol. 174 (2005), 7592–7599.
94. [94] Pollizzi, K.N., Powell, J.D., Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 14 (2014), 435–446.
95. [95] Kojima, H., Gu, H., Nomura, S., Caldwell, C.C., Kobata, T., et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha -deficient chimeric mice. Proc. Natl. Acad. Sci. U S A 99 (2002), 2170–2174.
96. [96] Dang, E.V., Barbi, J., Yang, H.Y., Jinasena, D., Yu, H., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146 (2011), 772–784.
97. [97] Shi, L.Z., Wang, R., Huang, G., Vogel, P., Neale, G., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208 (2011), 1367–1376.
98. [98] Hwang, I.I., Watson, I.R., Der, S.D., Ohh, M., Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response. J. Virol. 80 (2006), 10712–10723.
99. [99] Spear, W., Chan, D., Coppens, I., Johnson, R.S., Giaccia, A., et al. The host cell transcription factor hypoxia-inducible factor 1 is required for Toxoplasma gondii growth and survival at physiological oxygen levels. Cell. Microbiol. 8 (2006), 339–352.
100. [100] Degrossoli, A., Bosetto, M.C., Lima, C.B., Giorgio, S., Expression of hypoxia-inducible factor 1alpha in mononuclear phagocytes infected with Leishmania amazonensis. Immunol. Lett. 114 (2007), 119–125.
101. [101] Arrais-Silva, W.W., Paffaro, V.A. Jr., Yamada, A.T., Giorgio, S., Expression of hypoxia-inducible factor-1alpha in the cutaneous lesions of BALB/c mice infected with Leishmania amazonensis. Exp. Mol. Pathol. 78 (2005), 49–54.
102. [102] Cardoso, M.S., Silva, T.M., Resende, M., Appelberg, R., Borges, M., Lack of the transcription factor hypoxia-inducible factor 1alpha (HIF-1alpha) in macrophages accelerates the necrosis of mycobacterium avium-induced granulomas. Infect. Immun. 83 (2015), 3534–3544.
103. [103] Berger, E.A., McClellan, S.A., Vistisen, K.S., Hazlett, L.D., HIF-1alpha is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis. PLoS Pathog., 9, 2013, e1003457.
104. [104] Matak, P., Heinis, M., Mathieu, J.R., Corriden, R., Cuvellier, S., et al. Myeloid HIF-1 is protective in Helicobacter pylori-mediated gastritis. J. Immunol. 194 (2015), 3259–3266.
105. [105] Mazzon, M., Peters, N.E., Loenarz, C., Krysztofinska, E.M., Ember, S.W., et al. A mechanism for induction of a hypoxic response by vaccinia virus. Proc. Natl. Acad. Sci. U S A 110 (2013), 12444–12449.
106. [106] Mazzon, M., Castro, C., Roberts, L.D., Griffin, J.L., Smith, G.L., A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism. J. Gen. Virol. 96 (2015), 395–407.
107. [107] Kilani, M.M., Mohammed, K.A., Nasreen, N., Tepper, R.S., Antony, V.B., RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells. Inflammation 28 (2004), 245–251.
108. [108] Zinkernagel, A.S., Johnson, R.S., Nizet, V., Hypoxia inducible factor (HIF) function in innate immunity and infection. J. Mol. Med. (Berl) 85 (2007), 1339–1346.
109. [109] Yoo, Y.G., Oh, S.H., Park, E.S., Cho, H., Lee, N., et al. Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway. J. Biol. Chem. 278 (2003), 39076–39084.
110. [110] Moon, E.J., Jeong, C.H., Jeong, J.W., Kim, K.R., Yu, D.Y., et al. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J. 18 (2004), 382–384.
111. [111] Nasimuzzaman, M., Waris, G., Mikolon, D., Stupack, D.G., Siddiqui, A., Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J. Virol. 81 (2007), 10249–10257.
112. [112] Birner, P., Schindl, M., Obermair, A., Plank, C., Breitenecker, G., et al. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 60 (2000), 4693–4696.
113. [113] Tomita, M., Semenza, G.L., Michiels, C., Matsuda, T., Uchihara, J.N., et al. Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells. Biochem. J. 406 (2007), 317–323.
114. [114] Wakisaka, N., Kondo, S., Yoshizaki, T., Murono, S., Furukawa, M., et al. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol. Cell. Biol. 24 (2004), 5223–5234.
115. [115] Kondo, S., Seo, S.Y., Yoshizaki, T., Wakisaka, N., Furukawa, M., et al. EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res. 66 (2006), 9870–9877.
116. [116] Deshmane, S.L., Mukerjee, R., Fan, S., Del Valle, L., Michiels, C., et al. Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J. Biol. Chem. 284 (2009), 11364–11373.
117. [117] Pina-Oviedo, S., Khalili, K., Del Valle, L., Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathy. Acta Neuropathol. 118 (2009), 235–247.
118. [118] Werth, N., Beerlage, C., Rosenberger, C., Yazdi, A.S., Edelmann, M., et al. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS ONE, 5, 2010, e11576.
119. [119] Carroll, P.A., Kenerson, H.L., Yeung, R.S., Lagunoff, M., Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors. J. Virol. 80 (2006), 10802–10812.
120. [120] Cai, Q.L., Knight, J.S., Verma, S.C., Zald, P., Robertson, E.S., EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog., 2, 2006, e116.
121. [121] Ng, S., March, S., Galstian, A., Hanson, K., Carvalho, T., et al. Hypoxia promotes liver-stage malaria infection in primary human hepatocytes in vitro. Dis. Model. Mech. 7 (2014), 215–224.
122. [122] Menendez, M.T., Teygong, C., Wade, K., Florimond, C., Blader, I.J., SiRNA screening identifies the host hexokinase 2 (HK2) gene as an important hypoxia-inducible transcription factor 1 (HIF-1) target gene in toxoplasma gondii-infected cells. MBio, 6, 2015, e00462.
123. [123] Wiley, M., Sweeney, K.R., Chan, D.A., Brown, K.M., McMurtrey, C., et al. Toxoplasma gondii activates hypoxia-inducible factor (HIF) by stabilizing the HIF-1alpha subunit via type I activin-like receptor kinase receptor signaling. J. Biol. Chem. 285 (2010), 26852–26860.
124. [124] Metheni, M., Echebli, N., Chaussepied, M., Ransy, C., Chereau, C., et al. The level of H(2)O(2) type oxidative stress regulates virulence of Theileria-transformed leukocytes. Cell. Microbiol. 16 (2014), 269–279.
125. [125] Araujo, A.P., Frezza, T.F., Allegretti, S.M., Giorgio, S., Hypoxia, hypoxia-inducible factor-1alpha and vascular endothelial growth factor in a murine model of Schistosoma mansoni infection. Exp. Mol. Pathol. 89 (2010), 327–333.
126. [126] El-On, J., Sneier, R., Elias, E., Leishmania major: bacterial contamination of cutaneous lesions in experimental animals. Isr. J. Med. Sci. 28 (1992), 847–851.
127. [127] Grimaldi, G. Jr., Tesh, R.B., Leishmaniases of the New World: current concepts and implications for future research. Clin. Microbiol. Rev. 6 (1993), 230–250.
128. [128] Singh, A.K., Mukhopadhyay, C., Biswas, S., Singh, V.K., Mukhopadhyay, C.K., Intracellular pathogen Leishmania donovani activates hypoxia inducible factor-1 by dual mechanism for survival advantage within macrophage. PLoS ONE, 7, 2012, e38489.
129. [129] Blackwell, J.M., Searle, S., Goswami, T., Miller, E.N., Understanding the multiple functions of Nramp1. Microbes Infect. 2 (2000), 317–321.
130. [130] Vidal, S., Tremblay, M.L., Govoni, G., Gauthier, S., Sebastiani, G., et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182 (1995), 655–666.
131. [131] Bayele, H.K., Peyssonnaux, C., Giatromanolaki, A., Arrais-Silva, W.W., Mohamed, H.S., et al. HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite. Blood 110 (2007), 3039–3048.
132. [132] Degrossoli, A., Arrais-Silva, W.W., Colhone, M.C., Gadelha, F.R., Joazeiro, P.P., et al. The influence of low oxygen on macrophage response to Leishmania infection. Scand. J. Immunol. 74 (2011), 165–175.
133. [133] Hammami, A., Charpentier, T., Smans, M., Stager, S., IRF-5-mediated inflammation limits CD8+ T cell expansion by inducing HIF-1alpha and impairing dendritic cell functions during Leishmania infection. PLoS Pathog., 11, 2015, e1004938.
134. [134] Paun, A., Bankoti, R., Joshi, T., Pitha, P.M., Stager, S., Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. PLoS Pathog., 7, 2011, e1001246.